UPDATE : Tuesday, August 11, 2020
Helixmith presents study results of neuropathic pain treatment
Helixmith unveiled the outcome of its study on developing a treatment for p...
by Shim Hyun-tai  |  2020-02-05 18:43
‘Baricitinib emerges as potential treatment for new coronavirus’
Benevolent AI, a U.K.-based artificial intelligence (AI) healthcare firm, h...
by Lee Han-soo  |  2020-02-05 16:32
Medytox, Daewoong in final battle over BTX strain ownership
The legal dispute between Medytox and Daewoong Pharmaceutical over the sour...
by Jeong Sae-im  |  2020-02-05 12:41
Interferon, Kaletra to get insurance benefit for new coronavirus treatment
The government said it would allow health insurance benefits for patients w...
by Kim Yun-mi  |  2020-02-04 16:39
‘Gilead’s drug candidate effective to fight new coronavirus’
Gilead Sciences’ antiviral drug candidate, remdesivir, showed efficacy in t...
by Kim Yun-mi  |  2020-02-04 16:39
Boryung Holdings sets up US offshoot
Boryung Holdings said that it has established a subsidiary, Hayan Health Ne...
by Lee Han-soo  |  2020-02-03 16:28
Drug firms minimize gatherings, hospital visits as coronavirus fear spreads
The local pharmaceutical industry is canceling annual events and meetings a...
by Jeong Sae-im  |  2020-02-03 15:21
New coronavirus affect related stocks in different ways
Amid mounting fears of the new coronavirus infection, share prices of relat...
by Jeong Sae-im  |  2020-01-30 17:36
Celltrion tops list of pharmaceutical brand reputation in January
Celltrion took the top place in the domestic brand reputation list of pharm...
by Jeong Sae-im  |  2020-01-30 16:10
Merck Korea worker commits suicide
After Merck Biopharma Korea shut down the general medicine (GM) division la...
by Kim Yun-mi  |  2020-01-30 16:09
Astellas’ rheumatoid arthritis drug Smyraf wins regulatory nod
Astellas Pharma’s Smyraf (ingredient: peficitinib) obtained regulatory appr...
by Kim Yun-mi  |  2020-01-30 14:07
Hanmi targets revenue of ₩100 billion from Rosuzet sales
Hanmi Pharmaceutical said it aims to earn 100 billion won ($85 million) fro...
by Shim Hyun-tai  |  2020-01-29 18:05
Drugmaker cancels event for 1,000 doctors due to new coronavirus risk
The outbreak of China’s novel coronavirus is affecting not only the medical...
by Park Gi-taek  |  2020-01-29 15:51
‘Dupixent revolutionary atopic dermatitis drug to end lack of fundamental treatment’
Sanofi's Dupixent (ingredient: dupilumab), the only biologic drug for a...
by Kim Yun-mi  |  2020-01-29 14:00
Afstyla wins nod as new therapy for hemophilia A
Afstyla, a new preventive treatment for hemophilia A developed in Korea, ha...
by Kim Yun-mi  |  2020-01-24 08:18
MIT promotes industrial liaison program to Korean drugmakers
“In Boston, corporations are making successful cases through collaboration ...
by Jeong Sae-im  |  2020-01-23 12:04
'Reimbursement for Repatha to expand treatment options for ASCVD patients'
Amgen is set to expand treatment options for atherosclerotic cardiovascular...
by Lee Han-soo  |  2020-01-22 15:14
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019
The domestic sales of sodium-glucose transport protein-2 (SGLT-2) inhibitor...
by Kim Yun-mi  |  2020-01-22 15:10
HanAll remains positive of eye treatment’s efficacy despite initial failure
HanAll Biopharma said that it has failed to meet the primary endpoint for i...
by Lee Han-soo  |  2020-01-21 15:12
SK Biopharma’s US partner gets EMA nod for sleepiness treatment
Jazz Pharmaceuticals, SK Biopharmaceutical’s U.S. partner, has received sal...
by Lee Han-soo  |  2020-01-21 14:22
Back to Top